REFERENCES
  1. Abman SH, Bancalari E, Jobe A. The Evolution of Bronchopulmonary Dysplasia after 50 Years. Am J Respir Crit Care Med . 2017;195(4):421-424.
  2. Guaman MC, Gien J, Baker CD, Zhang H, Austin ED, Collaco JM. Point Prevalence, Clinical Characteristics, and Treatment Variation for Infants with Severe Bronchopulmonary Dysplasia. Am J Perinatol.2015;32(10):960-967.
  3. Greenberg RG, Gayam S, Savage D, et al. Furosemide Exposure and Prevention of Bronchopulmonary Dysplasia in Premature Infants. J Pediatr. 2019;208:134-140.e2.
  4. Slaughter JL, Stenger MR, Reagan PB. Variation in the use of diuretic therapy for infants with bronchopulmonary dysplasia. Pediatrics . 2013;131(4):716-723.
  5. Blaisdell CJ, Troendle J, Zajicek A; Prematurity and Respiratory Outcomes Program. Acute Responses to Diuretic Therapy in Extremely Low Gestational Age Newborns: Results from the Prematurity and Respiratory Outcomes Program Cohort Study. J Pediatr. 2018;197:42-47.e1.
  6. Kao LC, Warburton D, Sargent CW, Platzker AC, Keens TG. Furosemide acutely decreases airways resistance in chronic bronchopulmonary dysplasia. J Pediatr . 1983;103(4):624-629.
  7. Patel H, Yeh TF, Jain R, Pildes R. Pulmonary and renal responses to furosemide in infants with stage III-IV bronchopulmonary dysplasia. Am J Dis Child. 1985;139(9):917-919.
  8. Engelhardt B, Elliott S, Hazinski TA. Short- and long-term effects of furosemide on lung function in infants with bronchopulmonary dysplasia. J Pediatr. 1986;109(6):1034-1039.
  9. Flemmer A, Simbruner G, Muenzer S, et al. Effect of lung water content, manipulated by intratracheal furosemide, surfactant, or a mixture of both, on compliance and viscoelastic tissue forces in lung-lavaged newborn piglets. Crit Care Med.2000;28(6):1911-1917.
  10. Yeh TF, Shibli A, Leu ST, Raval D, Pildes RS. Early furosemide therapy in premature infants (less than or equal to 2000 gm) with respiratory distress syndrome: a randomized controlled trial. J Pediatr.1984;105(4):603-609.
  11. Stewart A, Brion LP. Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease. Cochrane Database Syst Rev. 2011;2011(9):CD001453. Published 2011 Sep 7.
  12. Stewart A, Brion LP, Ambrosio-Perez I. Diuretics acting on the distal renal tubule for preterm infants with (or developing) chronic lung disease. Cochrane Database Syst Rev. 2011;2011(9):CD001817. Published 2011 Sep 7.
  13. Kurepa D, Zaghloul N, Watkins L, Liu J. Neonatal lung ultrasound exam guidelines. J Perinatol . 2018;38(1):11-22.
  14. Zong HF, Guo G, Liu J, Bao LL, Yang CZ. Using lung ultrasound to quantitatively evaluate pulmonary water content. Pediatr Pulmonol. 2020;55(3):729-739.
  15. Rodríguez-Fanjul J, Llop AS, Balaguer M, Bautista-Rodriguez C, Hernando JM, Jordan I. Usefulness of Lung Ultrasound in Neonatal Congenital Heart Disease (LUSNEHDI): Lung Ultrasound to Assess Pulmonary Overflow in Neonatal Congenital Heart Disease. Pediatr Cardiol. 2016;37(8):1482-1487.
  16. Yu LF, Xu CK, Zhao M, Niu L, Huang XM, Zhang ZQ. Bedside cardiopulmonary ultrasonography evaluates lung water content in very low-weight preterm neonates with patent ductus arteriosus. World J Clin Cases . 2021;9(8):1827-1834.
  17. Raimondi F, Migliaro F, Sodano A, et al. Can neonatal lung ultrasound monitor fluid clearance and predict the need of respiratory support?.Crit Care. 2012;16(6):R220. Published 2012 Nov 14.
  18. De Martino L, Yousef N, Ben-Ammar R, Raimondi F, Shankar-Aguilera S, De Luca D. Lung Ultrasound Score Predicts Surfactant Need in Extremely Preterm Neonates. Pediatrics. 2018;142(3):e20180463.
  19. Raimondi F, Migliaro F, Sodano A, et al. Use of neonatal chest ultrasound to predict noninvasive ventilation failure.Pediatrics. 2014;134(4):e1089-e1094.
  20. Rodríguez-Fanjul J, Balcells C, Aldecoa-Bilbao V, Moreno J, Iriondo M. Lung Ultrasound as a Predictor of Mechanical Ventilation in Neonates Older than 32 Weeks. Neonatology. 2016;110(3):198-203.
  21. Girona-Alarcón M, Cuaresma-González A, Rodríguez-Fanjul J, et al. LUCAS (lung ultrasonography in cardiac surgery) score to monitor pulmonary edema after congenital cardiac surgery in children. J Matern Fetal Neonatal Med. 2022;35(6):1213-1218.
  22. Alonso-Ojembarrena A, Lubián-López SP. Lung ultrasound score as early predictor of bronchopulmonary dysplasia in very low birth weight infants. Pediatr Pulmonol. 2019;54(9):1404-1409.
  23. Alonso-Ojembarrena A, Lechuga-Sancho AM, Morales-Arandojo P, Acuñas-Soto S, López-de-Francisco R, Lubián-López SP. Lung ultrasound score and diuretics in preterm infants born before 32 weeks: A pilot study. Pediatr Pulmonol. 2020;55(12):3312-3318.
  24. Mirochnick MH, Miceli JJ, Kramer PA, Chapron DJ, Raye JR. Renal response to furosemide in very low birth weight infants during chronic administration. Dev Pharmacol Ther. 1990;15(1):1-7.
  25. Segar JL, Robillard JE, Johnson KJ, Bell EF, Chemtob S. Addition of metolazone to overcome tolerance to furosemide in infants with bronchopulmonary dysplasia. J Pediatr. 1992;120(6):966-973.
  26. Rush MG, Engelhardt B, Parker RA, Hazinski TA. Double-blind, placebo-controlled trial of alternate-day furosemide therapy in infants with chronic bronchopulmonary dysplasia. J Pediatr.1990;117(1 Pt 1):112-118.
  27. Nelin TD, Lorch S, Jensen EA, et al. The association between diuretic class exposures and enteral electrolyte use in infants developing grade 2 or 3 bronchopulmonary dysplasia in United States children’s hospitals. J Perinatol. 2021;41(4):779-785.
  28. Bamat NA, Nelin TD, Eichenwald EC, et al. Loop Diuretics in Severe Bronchopulmonary Dysplasia: Cumulative Use and Associations with Mortality and Age at Discharge. J Pediatr. 2021;231:43-49.e3.
CONFLICTS OF INTEREST
The authors declare no conflicts of interest.
AUTHOR CONTRIBUTIONS
Kasniya Gangajal - US scanning (lead), writing original draft (co-lead), conceptualization (co-lead),
Barry Weinberger - original draft review and editing (equal)
Jane Cerise - data analysis (lead)
Margaret Pulju - original draft review and editing (equal),
Vitaliya Boyar - original draft review and editing (equal), study supervision (lead) Florin Frunza - US scanning (supporting)
Dalibor Kurepa - conceptualization (lead), US scanning (supporting), writing original draft (lead).
DATA AVAILABILITY STATEMENT
The data that support the findings of this study are available in RedCap data base.